Atezolizumab/Bevacizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of atezolizumab and bevacizumab that can be used in the treatment of non-small cell lung cancer (NSCLC), peritoneal mesothelioma and hepatocellular carcinoma (HCC).

**Synonyms:** - Atezolizumab and Bevacizumab - Atezolizumab and Bevacizumab-adcd - Atezolizumab and Bevacizumab-awwb - Atezolizumab and Bevacizumab-aybi - Atezolizumab and Bevacizumab-bvzr - Atezolizumab and Bevacizumab-equi - Atezolizumab and Bevacizumab-maly - Atezolizumab and Bevacizumab-onbe - Atezolizumab and Bevacizumab-tnjn - Atezolizumab-Bevacizumab - Atezolizumab-Bevacizumab Regimen - Atezolizumab/Bevacizumab - Tecentriq/Avastin